Constitutive Association of BRCA1 and c-Abl and Its ATM-Dependent Disruption after Irradiation

REFERENCES

• Aprelikova, O. N., B. S. Fang, E. G. Meissner, S. Cotter, M. Campbell, A. Kuthiala, M. Bessho, and R. A. Jensen. 1999. BRCA1-associated growth arrest is RB-dependent. Proc. Natl. Acad. Sci. USA 96: 11866–11871.
   PubMed Web of Science ®Google Scholar
• Barila, D., and G. Superti-Furga. 1998. An intermolecular SH3-domain interaction regulates c-Abl activity. Nat. Genet. 18: 280–282.
   PubMed Web of Science ®Google Scholar
• Baskaran, R., M. E. Dahmus, and J. Y. Wang. 1993. Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain. Proc. Natl. Acad. Sci. USA 90: 11167–11171.
   PubMed Web of Science ®Google Scholar
• Baskaran, R., L. D. Wood, L. L. Whitaker, C. E. Canman, S. E. Morgan, Y. Xu, C. Barlow, D. Baltimore, A. Wynshaw-Boris, M. B. Kastan, and J. Y. J. Wang. 1997. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 387: 516–519.
   PubMed Web of Science ®Google Scholar
• Bressan, D. A., B. K. Baxter, and J. H. Petrini. 1999. The Mre11-Rad50-Xrs2 protein complex facilitates homologous recombination-based double-strand break repair in Saccharomyces cerevisiae. Mol. Cell. Biol. 11: 7681–7687.
   Google Scholar
• Brzovic, P. S., P. Rajagopal, D. W. Hoyt, M. C. King, and R. E. Klevit. 2001. Structure of a BRCA1-BARD1 heterodimeric RING-RING complex. Nat. Struct. Biol. 8: 833–837.
   PubMedGoogle Scholar
• Callebaut, I., and J. P. Mornon. 1997. From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Lett. 400: 25–30.
   PubMed Web of Science ®Google Scholar
• Cantor, S. B., D. W. Bell, S. Ganesan, E. M. Kass, R. Drapkin, S. Grossman, D. C. R. Wharer, D. C. Sgroi, W. S. Lane, and D. A. Haber. 2001. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105: 149–160.
   PubMed Web of Science ®Google Scholar
• Chen, J., D. P. Silver, D. Walpita, S. B. Cantor, A. F. Gazdar, G. Tomlinson, F. J. Couch, T. Ashley, D. M. Livingston, and R. Scully. 1998. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol. Cell 2: 317–328.
   PubMed Web of Science ®Google Scholar
• Chen, J. J., D. Silver, S. Cantor, D. M. Livingston, and R. Scully. 1999. BRCA1, BRCA2 and Rad51 operate in a common DNA damage response pathway. Cancer Res. 59: 1752s-1756s.
   PubMedGoogle Scholar
• Chiba, N., and J. D. Parvin. 2001. Redistribution of BRCA1 among four different protein complexes following replication blockage. J. Biol. Chem. 276: 38459–38554.
   Google Scholar
• Cortez, D., Y. Wang, and J. Qin. 1999. Requirement of ATM-dependent phosphorylation of Brca1 in the DNA damage response to DNA double-strand breaks. Science 286: 1162–1166.
   PubMed Web of Science ®Google Scholar
• Daley, G. Q., and Y. Ben-Neriah. 1991. Implicating the brc/abl gene in the pathogenesis of Philadelphia chromosome-positive human leukemia. Adv. Cancer Res. 57: 151–184.
   PubMed Web of Science ®Google Scholar
• Deng, C.-X., and S. G. Brodie. 2000. Roles of BRCA1 and its interacting proteins. Bioessays 22: 726–737.
   Google Scholar
• Easton, D. F., D. T. Bishop, D. Ford, G. P. Crockford, and The Breast Cancer Consortium. 1993. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am. J. Hum. Genet. 52: 678–701.
   PubMed Web of Science ®Google Scholar
• Garcia-Higuera, I., T. Taniguchi, S. Ganesan, M. S. Meyn, C. Timmers, J. Hejna, A. Grompe, and M. D'Andrea. 2001. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7: 249–262.
   PubMed Web of Science ®Google Scholar
• Gatei, M., S. P. Scott, I. Filippovitch, N. Soronika, M. F. Lavin, B. Weber, and K. K. Khanna. 2000. Role for ATM in DNA damage-induced phosphorylation of BRCA1. Cancer Res. 60: 3299–3304.
   PubMed Web of Science ®Google Scholar
• Gatei, M., B. B. Zhou, K. Hobson, S. Scott, D. Young, and K. K. Khanna. 2001. Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies. J. Biol. Chem. 276: 17276–17280.
   PubMed Web of Science ®Google Scholar
• Harkin, D. P., J. M. Bean, D. Miklos, Y. H. Song, V. B. Truong, C. Englert, F. C. Christians, L. W. Ellisen, S. Maheswaran, J. D. Oliner, and D. A. Haber. 1999. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 97: 575–586.
   PubMed Web of Science ®Google Scholar
• Huyton, T., P. A. Bates, X. Zhang, M. J. E. Sterberg, and P. S. Freemont. 2000. The BRCA1 C-terminal domain: structure and function. Mutat. Res. 460: 319–332.
   PubMed Web of Science ®Google Scholar
• Jin, S., S. Kharbanda, B. Mayer, D. Kufe, and D. T. Weaver. 1997. Binding of Ku and c-Abl at the kinase homology region of DNA-dependent protein kinase catalytic subunit. J. Biol. Chem. 272: 24763–24766.
   PubMed Web of Science ®Google Scholar
• Kaelin, W. G. J., W. Krek, W. R. Sellers, J. A. DeCaprio, F. Ajchenbaum, C. S. Fuchs, T. Chittenden, Y. Li, P. J. Farnham, et al. 1992. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70: 351–364.
   PubMed Web of Science ®Google Scholar
• Kharbanda, S., R. Ren, P. Pandey, T. D. Shafman, S. M. Feller, R. R. Weichselbaum, and D. W. N. Kufe. 1995. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature 376: 785–788.
   PubMed Web of Science ®Google Scholar
• Kharbanda, S., Z. M. Yuan, R. Weichselbaum, and D. Kufe. 1998. Determination of cell fate by c-Abl activation in the response to DNA damage. Oncogene 17: 3309–3318.
   PubMed Web of Science ®Google Scholar
• Kinzler, K. W., and B. Vogelstein. 1997. Cancer-susceptibility genes: gatekeepers and caretakers. Nature 386: 761–763.
   PubMed Web of Science ®Google Scholar
• Lee, J. S., K. M. Collins, A. L. Brown, C. H. Lee, and J. H. Chung. 2000. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 404: 201–204.
   PubMed Web of Science ®Google Scholar
• Li, S., N. S. Ting, L. Zheng, P. L. Chen, Y. Ziv, Y. Shiloh, E. Y. Lee, and W. H. Lee. 2000. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Nature 406: 210–215.
   PubMed Web of Science ®Google Scholar
• Mayer, B. J., and D. Baltimore. 1994. Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase. Mol. Cell. Biol. 14: 2883–2894.
   PubMed Web of Science ®Google Scholar
• Mayer, B. J., P. K. Jackson, and D. Baltimore. 1991. The noncatalytic src homology region 2 segment of abl tyrosine kinase binds to tyrosine-phosphorylated cellular proteins with high affinity. Proc. Natl. Acad. Sci. USA 88: 627–631.
   PubMedGoogle Scholar
• Olnes, M. I., and R. N. Kurl. 1994. Isolation of nuclear extracts from fragile cells: a simplified procedure applied to thymocytes. BioTechniques 17: 828–829.
   PubMedGoogle Scholar
• Randrianarison, V., D. Marot, N. Foray, J. Cabannes, V. Meret, E. Connault, N. Vitrat, P. Opolon, M. Perricaudet, and J. Feunteun. 2001. BRCA1 carries tumor suppressor activity distinct from that of p53 and p21. Cancer Gene Ther. 8: 759–770.
   PubMedGoogle Scholar
• Ruffner, H., and I. M. Verma. 1997. BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc. Natl. Acad. Sci. USA 94: 7138–7143.
   PubMed Web of Science ®Google Scholar
• Scully, R., J. Chen, R. L. Ochs, K. Keegan, M. Hoekstra, J. Feunteun, and D. M. Livingston. 1997. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90: 425–435.
   PubMed Web of Science ®Google Scholar
• Scully, R., J. Chen, A. Plug, Y. Xiao, D. Weaver, J. Feunteun, T. Ashley, and D. M. Livingston. 1997. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88: 1–20.
   PubMedGoogle Scholar
• Shafman, T., K. K. Khanna, P. Kedar, K. Spring, S. Kozlov, T. Yen, K. Hobson, M. Gatei, N. Zhang, D. Watters, M. Egerton, Y. Shiloh, S. Kharbanda, D. Kufe, and M. F. Lavin. 1997. Interaction between ATM protein and c-Abl in response to DNA damage. Nature 387: 520–522.
   PubMed Web of Science ®Google Scholar
• Shaul, Y. 2000. C-Abl: activation and nuclear targets. Cell Death Differ. 7: 10–16.
   PubMed Web of Science ®Google Scholar
• Slupianek, A., C. Schmutte, G. Tombline, M. Nieborowska-Skorska, G. Hoser, M. O. Nowicki, A. J. Pierce, R. Fishel, and T. Skroski. 2001. BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance. Mol. Cell 8: 795–806.
   PubMed Web of Science ®Google Scholar
• Tibbetts, R. S., D. Cortez, K. M. Brumbaugh, R. Scully, D. Livingston, S. J. Elledge, and R. T. Abraham. 2000. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. 14: 2989–3002.
   PubMed Web of Science ®Google Scholar
• Tomlinson, G. E., T. T. Chen, V. A. Stastny, M. A. Spillman, V. Tonk, J. L. Blum, N. R. Schneider, I. I. Wistuba, J. W. Shay, J. D. Minna, and A. F. Gazdar. 1999. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Res. 58: 3237–3242.
   Google Scholar
• Tybulewicz, V. L., C. E. Crawford, P. K. Jackson, R. T. Bronson, and R. C. Mulligan. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-Abl proto-oncogene. Cell 65: 1153–1163.
   PubMed Web of Science ®Google Scholar
• Umezawa, K., and M. Imoto. 1991. Use of erbstatin as protein-tyrosine kinase inhibitor. Methods Enzymol. 201: 379–385.
   PubMed Web of Science ®Google Scholar
• Wang, A., R. Schneider-Broussard, A. P. Kumar, M. C. MacLeod, and D. G. Johnson. 2000. Regulation of BRCA1 expression by the Rb-E2F pathway. J. Biol. Chem. 275: 4532–4536.
   PubMed Web of Science ®Google Scholar
• Wang, H., N. Shao, Q. Ming Ding, J.-Q. Cui, E. Shyam, P. Reddy, and V. N. Rao. 1997. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases. Oncogene 15: 143–157.
   PubMed Web of Science ®Google Scholar
• Wang, J. Y. 2001. Regulation of cell death by the Abl tyrosine kinase. Oncogene 19: 5643–5650.
   Google Scholar
• Wang, T., D. Cortez, P. Yazdi, N. Neff, S. J. Elledge, and J. Qin. 2000. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14: 927–939.
   PubMed Web of Science ®Google Scholar
• Welch, P. J., and Y. J. Wang. 1993. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75: 779–790.
   PubMed Web of Science ®Google Scholar
• Williams, R. S., R. Green, and J. N. Glover. 2001. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1. Nat. Struct. Biol. 8: 838–842.
   PubMedGoogle Scholar
• Young, M. A., S. Gonfloni, G. Superti-Furga, B. Roux, and J. Kuriyan. 2001. Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation. Cell 105: 115–126.
   PubMed Web of Science ®Google Scholar
• Yuan, Z.-M., Y. Huang, T. Ishiko, S. Nakada, T. Utsugisawa, S. Kharbanda, R. Wang, P. Sung, A. Shinohara, R. Weichselbaum, and D. Kufe. 1998. Regulation of Rad51 function by c-Abl in response to DNA damage. J. Biol. Chem. 13: 3799–3802.
   Google Scholar
• Zhang, H., G. Tombline, and B. L. Weber. 1998. BRCA1, BRCA2 and DNA damage response: collision or collusion? Cell 92: 433–436.
   PubMed Web of Science ®Google Scholar
• Zhang, H. T., X. Zhang, H. Z. Zhao, Y. Kajino, B. L. Weber, J. G. Davis, Q. Wang, D. M. O'Rourke, H. B. Zhang, K. Kajino, and M. I. Greene. 1997. Relationship of p215 BRCA1 to tyrosine kinase signaling pathways and the cell cycle in normal and transformed cells. Oncogene 14: 2863–2869.
   PubMedGoogle Scholar
• Zhong, Q., C. F. Chen, S. Li, Y. Chen, C. C. Wang, J. Xiao, P. L. Chen, Z. D. Sharp, and W. H. Lee. 1999. Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science 285: 747–750.
   PubMed Web of Science ®Google Scholar